ClassID:

95260

C07D405/12 - page 8 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2101
20190269692
2019-09-05

Salt form of a human histone methyltransferase EZH2 inhibitor

#2102
20190269650
2019-09-05

Somatostatin receptor subtype 4 (SSTR4) agonists

#2103
20190269134
2019-09-05

Substituted sulfonyl amides for controlling animal pests

#2104
20190263843
2019-08-29

Substituted piperidine compound and use thereof

#2105
20190263792
2019-08-29

Chromene derivatives as inhibitors of TCR-NCK interaction

#2106
20190263789
2019-08-29

Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis

#2107
20190263775
2019-08-29

Glucosylceramide synthase inhibitors for the treatment of diseases

#2108
20190263771
2019-08-29

Processes for preparing antiviral compounds

#2109
20190263758
2019-08-29

ACSS2 inhibitors and methods of use thereof

#2110
20190263757
2019-08-29

3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#2111
20190263754
2019-08-29

Antiviral compounds

#2112
20190263742
2019-08-29

Hydroxyl compounds and compositions for cholesterol management and related uses

#2113
20190262324
2019-08-29

Pyridine and Pyrazine Derivative for the Treatment of CF

#2114
20190256505
2019-08-22

Phthalazinone compounds and methods for the treatment of cystic fibrosis

#2115
20190256492
2019-08-22

Alpha-synuclein ligands

#2116
20190256482
2019-08-22

Diaryl thioether piperazine compounds, preparation methods and uses thereof

#2117
20190256476
2019-08-22

Compositions and methods for inhibition of the JAK pathway

#2118
20190256475
2019-08-22

Kinase inhibitors for the treatment of disease

#2119
20190255062
2019-08-22

DNA-PK inhibitors

#2120
20190255047
2019-08-22

2,4-pyrimidinediamine compounds and their uses

#2121
20190248836
2019-08-15

DNA primase and gyrase inhibitors

#2122
20190248806
2019-08-15

ULK1 inhibitors and methods using same

#2123
20190248805
2019-08-15

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#2124
20190248768
2019-08-15

Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form

#2125
20190248745
2019-08-15

Pyridone amides as modulators of sodium channels

#2126
20190248739
2019-08-15

SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN

#2127
20190241574
2019-08-08

Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same

#2128
20190241546
2019-08-08

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

#2129
20190241535
2019-08-08

3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof

#2130
20190241533
2019-08-08

Compounds and compositions for inhibition of FASN

#2131
20190241532
2019-08-08

Compounds and compositions for inhibition of FASN

#2132
20190241531
2019-08-08

Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#2133
20190241528
2019-08-08

SODIUM CHANNEL BLOCKERS

#2134
20190241526
2019-08-08

Hsp70 modulators and methods for making and using the same

#2135
20190241521
2019-08-08

Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#2136
20190241506
2019-08-08

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#2137
20190240220
2019-08-08

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#2138
20190240188
2019-08-08

Small molecules against cancer

#2139
20190233405
2019-08-01

Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#2140
20190233387
2019-08-01

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#2141
20190233376
2019-08-01

Guanidine derivative and medical use thereof

#2142
20190230927
2019-08-01

3-amino-1,2,4-triazine derivatives and their use for controlling undesired plant growth

#2143
20190225598
2019-07-25

Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies

#2144
20190225593
2019-07-25

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

#2145
20190225592
2019-07-25

ANTI-INFECTIVE AGENTS

#2146
20190225587
2019-07-25

INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES

#2147
20190218212
2019-07-18

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

#2148
20190218196
2019-07-18

Furane derivatives as inhibitors of ATAD2

#2149
20190218194
2019-07-18

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2150
20190216810
2019-07-18

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#2151
20190211000
2019-07-11

Activators of class I histone deacetylases (HDACs) and uses thereof

#2152
20190210998
2019-07-11

Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof

#2153
20190210991
2019-07-11

PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

#2154
20190210970
2019-07-11

PHENYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

#2155
20190209550
2019-07-11

Azadecalin derivatives as inhibitors of human immunodeficiency virus replication

#2156
20190209536
2019-07-11

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#2157
20190202819
2019-07-04

Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))

#2158
20190202814
2019-07-04

PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN

#2159
20190202811
2019-07-04

Aminoacylindazole immunomodulators for treatment of autoimmune diseases

#2160
20190202790
2019-07-04

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#2161
20190194207
2019-06-27

Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease

#2162
20190194178
2019-06-27

Substituted ureas and methods of making and using same

#2163
20190194174
2019-06-27

Quinazolinones as PARP14 inhibitors

#2164
20190194173
2019-06-27

6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists

#2165
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#2166
20190194144
2019-06-27

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#2167
20190194132
2019-06-27

Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors

#2168
20190192526
2019-06-27

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

#2169
20190192516
2019-06-27

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

#2170
20190192512
2019-06-27

2,4-disubstituted pyrimidines useful as kinase inhibitors

#2171
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2172
20190185464
2019-06-20

Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof

#2173
20190185460
2019-06-20

AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

#2174
20190185451
2019-06-20

Inhibitors of fibroblast activation protein

#2175
20190185450
2019-06-20

1,3-dihydroxy-phenyl derivatives useful as immunomodulators

#2176
20190185443
2019-06-20

Cannabinergic compounds and uses thereof

#2177
20190185436
2019-06-20

Triazoles for the treatment of demyelinating dieases

#2178
20190185411
2019-06-20

Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof

#2179
20190177332
2019-06-13

Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

#2180
20190177310
2019-06-13

Inhibitors of integrated stress response pathway

#2181
20190177284
2019-06-13

TETRAZOLYL-CONTAINING CYCLOPROPANECARBOXAMIDES

#2182
20190177272
2019-06-13

2-pyrrolidine phenylhydrazides antibacterial agents

#2183
20190175606
2019-06-13

Biaryl amide compounds as kinase inhibitors

#2184
20190175604
2019-06-13

EZH2 INHIBITORS FOR TREATING LYMPHOMA

#2185
20190175567
2019-06-13

Compounds and methods for kinase modulation, and indications therefor

#2186
20190169173
2019-06-06

Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

#2187
20190169166
2019-06-06

Heterocyclic compound

#2188
20190169138
2019-06-06

Small molecule regulators of mitochondrial fusion and methods of use thereof

#2189
20190169127
2019-06-06

Tubulin inhibitors

#2190
20190167800
2019-06-06

Lipids and compositions for the delivery of therapeutics

#2191
20190167666
2019-06-06

Methods for treating depressive symptoms

#2192
20190167636
2019-06-06

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#2193
20190161479
2019-05-30

Compounds

#2194
20190161478
2019-05-30

Plants having increased tolerance to herbicides

#2195
20190161449
2019-05-30

Oxoacridinyl acetic acid derivatives and methods of use

#2196
20190161447
2019-05-30

Indole derivatives and their use in neurodegenerative diseases

#2197
20190161445
2019-05-30

Urea derivative or pharmacologically acceptable salt thereof

#2198
20190160083
2019-05-30

Catecholamine prodrugs for use in the treatment of Parkinson's disease

#2199
20190157560
2019-05-23

Compound for organic electronic element, organic electronic element using same, and electronic device comprising same

#2200
20190152991
2019-05-23

PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES

#2201
20190152989
2019-05-23

ULK1 inhibitors and methods using same

#2202
20190152943
2019-05-23

Tetrahydroindazoles and medical uses thereof

#2203
20190152938
2019-05-23

Compounds for treating parasitic infections

#2204
20190152937
2019-05-23

Benzo-fused heterocyclic derivatives useful as agonists of GPR120

#2205
20190152922
2019-05-23

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#2206
20190152919
2019-05-23

Compound and organic electronic element comprising same

#2207
20190152913
2019-05-23

1,4-substituted piperidine derivatives

#2208
20190152891
2019-05-23

Complex and structurally diverse compounds

#2209
20190148640
2019-05-16

ORGANIC LIGHT-EMITTING DEVICE

#2210
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

#2211
20190144464
2019-05-16

BIGUANIDE COMPOUNDS AND USE THEREOF

#2212
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

#2213
20190144446
2019-05-16

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

#2214
20190144434
2019-05-16

Halogenated quinazolin-THF-amines as PDE1 inhibitors

#2215
20190144426
2019-05-16

Quinazolines as potassium ion channel inhibitors

#2216
20190144396
2019-05-16

9-MEMBERED FUSED RING DERIVATIVE

#2217
20190144386
2019-05-16

Inhibitors of integrin alpha 5 beta 1 and methods of use

#2218
20190144384
2019-05-16

Chemical compounds

#2219
20190144382
2019-05-16

MEK Inhibitors and Methods of Their Use

#2220
20190142802
2019-05-16

Benzopyrazole compounds and analogues thereof

#2221
20190135827
2019-05-09

Substituted Tricyclics and Method of Use

#2222
20190135819
2019-05-09

CARM1 inhibitors and uses thereof

#2223
20190135765
2019-05-09

Substituted pyrimidine-4-carboxylic acids having anticancer activity

#2224
20190135746
2019-05-09

Indoline derivatives and method for using and producing the same

#2225
20190135745
2019-05-09

Immunomodulator compounds

#2226
20190135730
2019-05-09

Compound for organic electric element, organic electric element using same, and electronic device comprising same organic electronic element

#2227
20190134025
2019-05-09

Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs

#2228
20190134022
2019-05-09

MODULATORS OF CELLULAR ADHESION

#2229
20190134018
2019-05-09

1-arylalkyl-4-acylaminopiperidine compounds

#2230
20190133128
2019-05-09

Fungicidal pyridazinones

#2231
20190131543
2019-05-02

Compound for organic electronic element, organic electronic element using same, and electronic device thereof

#2232
20190127365
2019-05-02

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#2233
20190127359
2019-05-02

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

#2234
20190127349
2019-05-02

Pyridazinone-based broad spectrum anti-influenza inhibitors

#2235
20190127346
2019-05-02

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#2236
20190125674
2019-05-02

Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

#2237
20190124924
2019-05-02

FUNGAL CONTROL OF WHITE MOLD

#2238
20190119295
2019-04-25

COMPOSITIONS AND METHODS FOR TREATING CANCER

#2239
20190119264
2019-04-25

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

#2240
20190119261
2019-04-25

N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease

#2241
20190119249
2019-04-25

Methods and compounds for restoring mutant p53 function

#2242
20190119248
2019-04-25

Pyridyl derivatives as bromodomain inhibitors

#2243
20190119224
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#2244
20190119223
2019-04-25

Modulators of indoleamine 2,3-dioxygenase

#2245
20190119219
2019-04-25

PKM2 modulators and methods for their use

#2246
20190119217
2019-04-25

Tyrosine kinase inhibitor and pharmaceutical composition comprising same

#2247
20190119212
2019-04-25

Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates

#2248
20190119211
2019-04-25

Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof

#2249
20190119203
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#2250
20190117668
2019-04-25

Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists

#2251
20190117661
2019-04-25

Therapeutically active compounds and their methods of use

#2252
20190117648
2019-04-25

Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders

#2253
20190112317
2019-04-18

ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES

#2254
20190112299
2019-04-18

Crystalline form of lumacaftor

#2255
20190112275
2019-04-18

Heterocyclic inhibitors of MCT4

#2256
20190112274
2019-04-18

MCT4 INHIBITORS FOR TREATING DISEASE

#2257
20190106430
2019-04-11

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2258
20190106413
2019-04-11

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I

#2259
20190105646
2019-04-11

Ion pair catalysis of tungstate and molybdate

#2260
20190100792
2019-04-04

Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same

#2261
20190100536
2019-04-04

Androgen receptor modulating compounds

#2262
20190100528
2019-04-04

EGFR inhibitor, preparation method and use thereof

#2263
20190100514
2019-04-04

METHODS OF TREATING CANCER

#2264
20190100507
2019-04-04

Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof

#2265
20190100497
2019-04-04

3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2266
20190100496
2019-04-04

Arginine methyltransferase inhibitors and uses thereof

#2267
20190100491
2019-04-04

HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#2268
20190099392
2019-04-04

Imaging composition and uses thereof

#2269
20190092765
2019-03-28

N-CYCLOALKYL-N-[(HETEROCYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES

#2270
20190092743
2019-03-28

Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device

#2271
20190092735
2019-03-28

Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

#2272
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

#2273
20190084980
2019-03-21

Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition

#2274
20190084972
2019-03-21

Pyrimidinyloxy benzene derivatives as herbicides

#2275
20190084969
2019-03-21

FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#2276
20190084968
2019-03-21

FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#2277
20190084955
2019-03-21

Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer

#2278
20190084933
2019-03-21

Indole derivatives for use in medicine

#2279
20190084908
2019-03-21

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#2280
20190083467
2019-03-21

Aromatic ring compound

#2281
20190082692
2019-03-21

2-amino-5-ketoxime-pyrimidine derivatives and their use for controlling undesired plant growth

#2282
20190077795
2019-03-14

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2283
20190077794
2019-03-14

Compositions and methods for treating infections

#2284
20190077793
2019-03-14

Bisamide sarcomere activating compounds and uses therof

#2285
20190077767
2019-03-14

Voltage-dependent t-type calcium channel blocker

#2286
20190077766
2019-03-14

Compositions for APP-selective BACE inhibition and uses therefor

#2287
20190077764
2019-03-14

Benzazepine dicarboxamide compounds with secondary amide function

#2288
20190077758
2019-03-14

Histone demethylase inhibitors

#2289
20190077757
2019-03-14

Trigonelline based compounds

#2290
20190076538
2019-03-14

Cholecystokinin B receptor targeting for imaging and therapy

#2291
20190076419
2019-03-14

Modulators of ATP-binding cassette transporters

#2292
20190076380
2019-03-14

Biguanide compositions and methods of treating metabolic disorders

#2293
20190071454
2019-03-07

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

#2294
20190071433
2019-03-07

Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))

#2295
20190071431
2019-03-07

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

#2296
20190071424
2019-03-07

Wnt signaling pathway inhibitors for treatments of disease

#2297
20190071404
2019-03-07

THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

#2298
20190071400
2019-03-07

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

#2299
20190071399
2019-03-07

Indole derivatives and their use as protein kinase inhibitors

#2300
20190070173
2019-03-07

Combinations for the treatment of neuroblastoma

#2301
20190070149
2019-03-07

PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#2302
20190062352
2019-02-28

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#2303
20190062317
2019-02-28

Compounds

#2304
20190062301
2019-02-28

Cyclopropylamines as LSD1 inhibitors

#2305
20190062290
2019-02-28

2,3-epoxy succinyl derivative, preparation method and use thereof

#2306
20190062281
2019-02-28

Substituted heterocycles as c-MYC targeting agents

#2307
20190062276
2019-02-28

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2308
20190062275
2019-02-28

C5aR ANTAGONISTS

#2309
20190060472
2019-02-28

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#2310
20190060322
2019-02-28

SUBSTITUTED BENZENE COMPOUNDS

#2311
20190060282
2019-02-28

Imidazolylamide derivative

#2312
20190059383
2019-02-28

Use of picolinamide compounds as fungicides

#2313
20190055239
2019-02-21

Glycosidase inhibitors

#2314
20190055233
2019-02-21

Acid addition salts of piperazine derivatives

#2315
20190055224
2019-02-21

Forms of lumacaftor and processes for the preparation thereof

#2316
20190055218
2019-02-21

AHR inhibitors and uses thereof

#2317
20190055205
2019-02-21

Methods for 1,4-diazo n-heterocycle synthesis

#2318
20190055203
2019-02-21

Potent dual BRD4-kinase inhibitors as cancer therapeutics

#2319
20190055196
2019-02-21

NUCLEAR RECEPTOR MODULATORS

#2320
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

#2321
20190047995
2019-02-14

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#2322
20190047968
2019-02-14

6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES

#2323
20190047966
2019-02-14

NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

#2324
20190040059
2019-02-07

Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity

#2325
20190040045
2019-02-07

Beta-arrestin-biased cannabinoid CBreceptor agonists and methods for making and using them

#2326
20190040044
2019-02-07

MCL-1 antagonists

#2327
20190040039
2019-02-07

Piperidine derivative

#2328
20190040029
2019-02-07

Type of aryl benzofuran amidated derivative and medical use thereof

#2329
20190040013
2019-02-07

Irreversible bruton's tyrosine kinase inhibitor

#2330
20190040012
2019-02-07

ROR GAMMA (RORY) MODULATORS

#2331
20190040010
2019-02-07

Heterocyclic compound and use thereof

#2332
20190038604
2019-02-07

BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF

#2333
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

#2334
20190031668
2019-01-31

Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists

#2335
20190031644
2019-01-31

Flavanone derivatives, and preparation method and use thereof

#2336
20190031637
2019-01-31

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#2337
20190031605
2019-01-31

Tetrahydronaphthalene derivative

#2338
20190030010
2019-01-31

Phenyl derivative

#2339
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2340
20190023698
2019-01-24

Coumarin based HSP90 inhibitors with urea and ether substituents

#2341
20190022064
2019-01-24

PRMT1 Inhibitors and Uses Thereof

#2342
20190016708
2019-01-17

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

#2343
20190016688
2019-01-17

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#2344
20190016671
2019-01-17

Carboxamides as modulators of sodium channels

#2345
20190013479
2019-01-10

Compound for organic-electric element, organic-electric element using same, and electronic device for same

#2346
20190013470
2019-01-10

REDUNDANT POWER LINE CONTROL SYSTEMS

#2347
20190010138
2019-01-10

Prodrugs of urolithins and uses thereof

#2348
20190010136
2019-01-10

α,β-unsaturated amide compound

#2349
20190010126
2019-01-10

Sulfonamide compounds and uses as TNAP inhibitors

#2350
20190010122
2019-01-10

2-cyanoisoindoline derivatives for treating cancer

#2351
20190008866
2019-01-10

BROMODOMAIN INHIBITORS

#2352
20190002472
2019-01-03

Immunoregulatory agents

#2353
20190002454
2019-01-03

NRF2 Regulators

#2354
20190002453
2019-01-03

Inhibitors of β-hydroxylase for treatment of cancer

#2355
20190002445
2019-01-03

Process for preparing lifitegrast and intermediates thereof

#2356
20190002444
2019-01-03

CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE

#2357
20190002443
2019-01-03

Substituted amide derivatives having multimodal activity against pain

#2358
20190002412
2019-01-03

Pyrimidines as sodium channel blockers

#2359
20190002406
2019-01-03

Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#2360
20190000856
2019-01-03

MTH1 inhibitors for treatment of inflammatory and autoimmune conditions

#2361
20190000849
2019-01-03

Compounds

#2362
20190000844
2019-01-03

Methods for treating Huntington's disease

#2363
20180375026
2018-12-27

Controlling zones of electronic devices associated with power lines

#2364
20180375025
2018-12-27

Methods and systems for wireless to power line communication

#2365
20180370966
2018-12-27

METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

#2366
20180370956
2018-12-27

Heteroaryl substituted pyridyl compounds useful as kinase modulators

#2367
20180370955
2018-12-27

Tank-binding kinase inhibitor compounds

#2368
20180370948
2018-12-27

P-TOLUENESULFONATE FOR MEK KINASE INHIBITOR, METHOD OF PREPARATION THEREOF, AND METHOD OF USE THEREOF

#2369
20180370933
2018-12-27

Compounds and compositions for inhibition of FASN

#2370
20180369215
2018-12-27

SIP modulating agents

#2371
20180368403
2018-12-27

PYRIDINE COMPOUNDS AS FUNGICIDES

#2372
20180364220
2018-12-20

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

#2373
20180362485
2018-12-20

N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS

#2374
20180362475
2018-12-20

Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death

#2375
20180362465
2018-12-20

Quinolone-3-diarylethers

#2376
20180362461
2018-12-20

Pyrrolidine derivatives

#2377
20180360795
2018-12-20

Fumigillol compounds and methods of making and using same

#2378
20180360046
2018-12-20

Benzamide compounds and their use as herbicides

#2379
20180358563
2018-12-13

Compound for organic electric device, organic electric device using same, and electronic device

#2380
20180354906
2018-12-13

Human plasma kallikrein inhibitors

#2381
20180354902
2018-12-13

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#2382
20180351111
2018-12-06

Heterocyclic compound and organic light emitting diode containing same

#2383
20180346449
2018-12-06

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

#2384
20180346448
2018-12-06

SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS

#2385
20180346438
2018-12-06

Modified compound of andrographolide

#2386
20180346423
2018-12-06

Pyridine compounds as fungicides

#2387
20180346420
2018-12-06

Carbon monoxide releasing norbornenone compounds

#2388
20180346416
2018-12-06

N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#2389
20180344723
2018-12-06

Rho kinase inhibitors

#2390
20180339972
2018-11-29

Lactone-based probes and methods of use thereof

#2391
20180338970
2018-11-29

Pyruvate kinase activators for use in therapy

#2392
20180334438
2018-11-22

PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

#2393
20180334435
2018-11-22

6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE

#2394
20180327418
2018-11-15

Pyridine derivative

#2395
20180327413
2018-11-15

Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

#2396
20180327397
2018-11-15

Lactam compound derivative and application thereof

#2397
20180327394
2018-11-15

Benzofuran derivative, preparation method thereof and use thereof in medicine

#2398
20180327393
2018-11-15

Aziridinated triglycerides and polymers formed therefrom

#2399
20180327381
2018-11-15

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#2400
20180327363
2018-11-15

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis